Kiniksa Pharmaceuticals International (KNSA) Tax Rate Growth (5y) (2022 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Tax Rate Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.72 Bn | 30.78 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.11 Bn | 20.96 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.88 Bn | 16.56 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.87 Bn | 4.40 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,130.00 |
| Dec 31, 2025 | -4,654.00 |
| Sep 30, 2025 | 3,366.00 |
| Dec 31, 2024 | -6,886.00 |
| Mar 31, 2024 | -2,404.00 |
| Dec 31, 2023 | -1,347.00 |
| Jun 30, 2023 | 130,741.00 |
| Mar 31, 2023 | -3,136.00 |
| Dec 31, 2022 | -21,251.00 |
| Sep 30, 2022 | -37,981.00 |
| Jun 30, 2022 | -404.00 |